Abstract:Real-world medical data often includes measurements from multiple signals that are collected at irregular and asynchronous time intervals. For example, different types of blood tests can be measured at different times and frequencies, resulting in fragmented and unevenly scattered temporal data. Similar issues of irregular sampling of different attributes occur in other domains, such as monitoring of large systems using event log files or the spread of fake news on social networks. Effectively learning from such data requires models that can handle sets of temporally sparse and heterogeneous signals. In this paper, we propose Graph Mixing Additive Networks (GMAN), a novel and interpretable-by-design model for learning over irregular sets of temporal signals. Our method achieves state-of-the-art performance in real-world medical tasks, including a 4-point increase in the AUROC score of in-hospital mortality prediction, compared to existing methods. We further showcase GMAN's flexibility by applying it to a fake news detection task. We demonstrate how its interpretability capabilities, including node-level, graph-level, and subset-level importance, allow for transition phases detection and gaining medical insights with real-world high-stakes implications. Finally, we provide theoretical insights on GMAN expressive power.
Abstract:Routinely collected clinical blood tests are an emerging molecular data source for large-scale biomedical research but inherently feature irregular sampling and informative observation. Traditional approaches rely on imputation, which can distort learning signals and bias predictions while lacking biological interpretability. We propose a novel methodology using Graph Neural Additive Networks (GNAN) to model biomarker trajectories as time-weighted directed graphs, where nodes represent sampling events and edges encode the time delta between events. GNAN's additive structure enables the explicit decomposition of feature and temporal contributions, allowing the detection of critical disease-associated time points. Unlike conventional imputation-based approaches, our method preserves the temporal structure of sparse data without introducing artificial biases and provides inherently interpretable predictions by decomposing contributions from each biomarker and time interval. This makes our model clinically applicable, as well as allowing it to discover biologically meaningful disease signatures.